| 07:00 | AVCT | FDA Approval of IND Application for AVA6000 | RNS |
| 18.11.2021 16:41 | AVCT | Second Price Monitoring Extn | RNS |
| 18.11.2021 16:36 | AVCT | Price Monitoring Extension | RNS |
| 02.11.2021 07:00 | AVCT | Update on UK Availability of AffiDX Test | RNS |
| 14.10.2021 16:36 | AVCT | Price Monitoring Extension | RNS |
| 14.10.2021 12:36 | AVCT | Issue of Equity and Total Voting Rights | RNS |
| 30.09.2021 07:00 | AVCT | Interim Results for the Period Ended 30 June 2021 | RNS |
| 29.09.2021 07:00 | AVCT | Development Milestone in LG Chem Partnership | RNS |
| 22.09.2021 16:41 | AVCT | Second Price Monitoring Extn | RNS |
| 22.09.2021 16:35 | AVCT | Price Monitoring Extension | RNS |
| 09.09.2021 07:00 | AVCT | Notice of Results | RNS |
| 06.09.2021 07:00 | AVCT | New appointments to Scientific Advisory Board | Reach |
| 02.09.2021 07:00 | AVCT | Appointment of Chief Scientific Officer | Reach |
| 25.08.2021 16:40 | AVCT | Second Price Monitoring Extn | RNS |
| 25.08.2021 16:35 | AVCT | Price Monitoring Extension | RNS |
| 18.08.2021 07:00 | AVCT | Directorate Change | RNS |
| 11.08.2021 07:00 | AVCT | First Patient Dosed in AVA6000 Phase 1 Trial | RNS |
| 04.08.2021 07:00 | AVCT | Update on AffiDX Lateral Flow Test | RNS |
| 14.07.2021 07:00 | AVCT | Diagnostics achieves ISO 13485 Certification | RNS |
| 12.07.2021 16:41 | AVCT | Second Price Monitoring Extn | RNS |
| 12.07.2021 16:35 | AVCT | Price Monitoring Extension | RNS |
| 29.06.2021 07:00 | AVCT | AffiDX Lateral Flow Test Detects Delta Variant | RNS |
| 28.06.2021 12:13 | AVCT | Result of AGM | RNS |
| 21.06.2021 14:05 | AVCT | Second Price Monitoring Extn | RNS |
| 21.06.2021 14:00 | AVCT | Price Monitoring Extension | RNS |
| 21.06.2021 07:00 | AVCT | AffiDX Lateral Flow Test Distribution Agreement | RNS |
| 15.06.2021 08:00 | AVCT | Issue of Equity and Total Voting Rights | RNS |
| 11.06.2021 14:05 | AVCT | Second Price Monitoring Extn | RNS |
| 11.06.2021 14:00 | AVCT | Price Monitoring Extension | RNS |
| 11.06.2021 11:07 | AVCT | Registration of AffiDX Lateral Flow Test in EU | RNS |
| 09.06.2021 09:08 | AVCT | Holding(s) in Company | RNS |
| 07.06.2021 07:00 | AVCT | MHRA Confirms Registration of Lateral Flow Test | RNS |
| 01.06.2021 07:00 | AVCT | Update on Lateral Flow Test Regulatory Submissions | RNS |
| 28.05.2021 07:00 | AVCT | Response to speculation | RNS |
| 25.05.2021 10:00 | AVCT | Posting of Annual Report and Notice of AGM | RNS |
| 10.05.2021 10:36 | AVCT | AffiDX SARS-CoV-2 Antigen Lateral Flow Test Update | RNS |
| 06.05.2021 07:00 | AVCT | Change of Nominated Adviser | RNS |
| 30.04.2021 12:37 | AVCT | Issue of Equity | RNS |
| 28.04.2021 17:18 | AVCT | Issue of Equity | RNS |
| 28.04.2021 16:41 | AVCT | Second Price Monitoring Extn | RNS |
| 28.04.2021 16:36 | AVCT | Price Monitoring Extension | RNS |
| 22.04.2021 07:00 | AVCT | Final Results | RNS |
| 20.04.2021 11:05 | AVCT | Second Price Monitoring Extn | RNS |
| 20.04.2021 11:00 | AVCT | Price Monitoring Extension | RNS |
| 20.04.2021 07:00 | AVCT | Clinical validation of AffiDX Lateral Flow Test | RNS |
| 15.04.2021 16:36 | AVCT | Price Monitoring Extension | RNS |
| 13.04.2021 07:00 | AVCT | Notice of Results and Investor Presentation | RNS |
| 12.04.2021 13:30 | AVCT | Issue of Equity | RNS |
| 06.04.2021 07:00 | AVCT | Distribution Agreement with ABCAM plc | RNS |
| 25.03.2021 15:01 | AVCT | Directorate Change | RNS |
| 16.03.2021 17:08 | AVCT | Issue of Equity | RNS |
| 15.03.2021 17:22 | AVCT | Issue of Equity | RNS |
| 09.03.2021 07:00 | AVCT | Diagnostic Licensing Deal with Biokit | RNS |
| 08.03.2021 07:00 | AVCT | Rapid Antigen Test Detects SARS-CoV-2 Variants | RNS |
| 03.03.2021 17:14 | AVCT | Electronic Communications with Shareholders | Reach |
| 24.02.2021 07:00 | AVCT | Business Update | RNS |
| 22.02.2021 07:00 | AVCT | Re: Press Speculation | RNS |
| 18.02.2021 07:00 | AVCT | Phase I CTA for AVA6000 Approved by MHRA | RNS |
| 16.02.2021 09:05 | AVCT | Second Price Monitoring Extn | RNS |
| 16.02.2021 09:00 | AVCT | Price Monitoring Extension | RNS |
| 16.02.2021 07:00 | AVCT | Results of Initial Evaluation of SARS-CoV-2 LFT | RNS |
| 08.02.2021 07:00 | AVCT | Commercial Partnership with Mologic | RNS |
| 02.02.2021 08:30 | AVCT | Issue of Equity | RNS |
| 01.02.2021 07:00 | AVCT | AffyXell $7.3 Million Series A Financing | RNS |
| 29.01.2021 11:00 | AVCT | Issue of Equity | RNS |
| 28.01.2021 07:00 | AVCT | Collaboration Agreement with Bruker | RNS |
| 07.01.2021 07:00 | AVCT | License Agreement with POINT Biopharma Inc. | RNS |
| 05.01.2021 11:05 | AVCT | Second Price Monitoring Extn | RNS |
| 05.01.2021 11:00 | AVCT | Price Monitoring Extension | RNS |
